Stay updated with breaking news from Polypid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PolyPid Ltd. (NASDAQ:PYPD – Get Free Report) was the recipient of a significant decline in short interest in November. As of November 15th, there was short interest totalling 1,000 shares, a decline of 68.8% from the October 31st total of 3,200 shares. Currently, 0.1% of the company’s shares are short sold. Based on an average […]
PolyPid Ltd. (NASDAQ:PYPD – Get Free Report) was the target of a significant drop in short interest in September. As of September 15th, there was short interest totalling 1,500 shares, a drop of 88.7% from the August 31st total of 13,300 shares. Based on an average trading volume of 5,500 shares, the short-interest ratio is […]
PolyPid Ltd. (NASDAQ:PYPD – Get Free Report) was the target of a significant decrease in short interest in the month of August. As of August 31st, there was short interest totalling 13,300 shares, a decrease of 81.3% from the August 15th total of 71,100 shares. Based on an average daily trading volume, of 66,000 shares, […]
PolyPid (NASDAQ:PYPD – Get Free Report) and Merit Medical Systems (NASDAQ:MMSI – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation. Profitability This table compares PolyPid and Merit Medical […]
Reached Agreement with U.S. FDA on Design of SHIELD II Phase 3 Trial Evaluating D-PLEX100 for the Prevention of Abdominal Colorectal Surgical Site Infections Resumed Recruitment into SHIELD II Phase 3 Trial in Late June 2023 Total of 20 centers in U.S., Europe and Israel Expected to be Opened by End of Current Quarter Conference Call Scheduled for Today at 8:30 AM ET PETACH TIKVA, Israel, Aug. 09, 2023 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage bio